Posters

A Review of Goal Attainment Scaling Implementation as a Personalized Clinical Outcome Assessment over the Last Decade

A Review of Goal Attainment Scaling Implementation as a Personalized Clinical Outcome Assessment over the Last Decade

The Symptoms, Challenges, and Issues of Prader-Willi Syndrome: The Development of a Conceptual Model

The Symptoms, Challenges, and Issues of Prader-Willi Syndrome: The Development of a Conceptual Model

Adaptation of Goal Attainment Scaling for Prader-Willi Syndrome: Development of a goal inventory for standardized implementation

Adaptation of Goal Attainment Scaling for Prader-Willi Syndrome: Development of a goal inventory for standardized implementation

ISPOR EU 2023: The Feasibility of Systematic Goal Quality Assurance During Goal Attainment Scaling in a Rare Disease

ISPOR EU 2023: The Feasibility of Systematic Goal Quality Assurance During Goal Attainment Scaling in a Rare Disease

ISPOR EU 2023: Inventory-facilitated Goal Attainment Scaling Interview conducted by disease experts is associated with a broader range of goal areas

ISPOR EU 2023: Inventory-facilitated Goal Attainment Scaling Interview conducted by disease experts is associated with a broader range of goal areas

ISPOR EU 2023: The Current Usage, Process and Challenges of Goal Attainment Scaling in Clinical Settings

ISPOR EU 2023: The Current Usage, Process and Challenges of Goal Attainment Scaling in Clinical Settings

Beyond Symptoms: Inventory-facilitated Goal Attainment Scaling is associated with a broader range of goal areas.

Beyond Symptoms: Inventory-facilitated Goal Attainment Scaling is associated with a broader range of goal areas.

A Qualitative Investigation of the Impact of the SARS CoV 2 Pandemic on Goal Attainment Scaling in a Clinical Research Setting

A Qualitative Investigation of the Impact of the SARS CoV 2 Pandemic on Goal Attainment Scaling in a Clinical Research Setting

The Feasibility of Goal Attainment Scaling in SCN2A-associated Neurodevelopmental Disorders

The Feasibility of Goal Attainment Scaling in SCN2A-associated Neurodevelopmental Disorders

The Feasibility of Goal Attainment Scaling in Adults with Down Syndrome: Early Results from the LIFE-DSR-GAS Sub-Study

The Feasibility of Goal Attainment Scaling in Adults with Down Syndrome: Early Results from the LIFE-DSR-GAS Sub-Study

The Goal Attainment Scaling Method is Robust to Violations of Normality in Goal Scales: A Simulation Study

The Goal Attainment Scaling Method is Robust to Violations of Normality in Goal Scales: A Simulation Study

What is the Minimum Number of Goals Required Per Subject for Goal Attainment Scaling Trials: A Simulation Study

What is the Minimum Number of Goals Required Per Subject for Goal Attainment Scaling Trials: A Simulation Study

Implementing GOAL-Hēm, A Goal Attainment Scaling Instrument

Implementing GOAL-Hēm, A Goal Attainment Scaling Instrument

Individualized Goal Attainment Scaling as a patient-reported outcome measure for Alzheimer disease and dementia

Individualized Goal Attainment Scaling as a patient-reported outcome measure for Alzheimer disease and dementia

A review of Goal Attainment Scaling in clinical trials

A review of Goal Attainment Scaling in clinical trials

Subscribe to GAS Newsletter

Sign up to receive the latest scientific updates on Goal Attainment Scaling.

Thank you, your submission has been received!

Oops! Something went wrong while submitting the form.